1. Home
  2. FTCI vs INO Comparison

FTCI vs INO Comparison

Compare FTCI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$5.37

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.18

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
INO
Founded
2017
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
100.4M
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
FTCI
INO
Price
$5.37
$1.18
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$10.80
$6.75
AVG Volume (30 Days)
97.6K
1.5M
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$99,687,000.00
$42,220,086.00
Revenue This Year
$65.44
$20,156.19
Revenue Next Year
$45.97
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
110.51
19.37
52 Week Low
$3.21
$1.03
52 Week High
$12.75
$2.86

Technical Indicators

Market Signals
Indicator
FTCI
INO
Relative Strength Index (RSI) 58.33 51.80
Support Level $4.20 $1.03
Resistance Level $5.38 $1.24
Average True Range (ATR) 0.38 0.06
MACD 0.03 0.01
Stochastic Oscillator 83.49 53.85

Price Performance

Historical Comparison
FTCI
INO

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: